POMPANO BEACH, FLORIDA, November 3, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announces that it has closed an oversubscribed private placement of common stock to accredited investors for an aggregate of 1,337,000 units (each, a “Unit”) at a price of $1.50 per Unit for gross proceeds of $2 million. Each Unit consists of one...
![BioStem Technologies Closes Oversubscribed $2M Private Placement](https://prismmediawire.com/wp-content/uploads/2023/10/BioStem-Technologies-Announces-Opening-of-First-Clinical-Site-for-Diabetic-Foot-Ulcer-Study-1080x675.png)